AR and neoplasm: On one hand, a tumor suppressive role has been attributed to AR signaling, whereby treatment of AR+ TNBC cell lines with AR agonists inhibited CSC phenotype (41), decreased EMT by upregulating AR inducible micro RNAs (42), and inhibited growth of xenograft tumors by modulating paracrine signaling (43).